home / stock / achv / achv news

ACHV News and Press, Achieve Life Sciences Inc. From 07/29/25

Stock Information
Company Name: Achieve Life Sciences Inc.
Stock Symbol: ACHV
Market: NASDAQ
Website: achievelifesciences.com
Menu
ACHV ACHV Quote ACHV Short ACHV News ACHV Articles ACHV Message Board
Get ACHV Alerts

News, Short Squeeze, Breakout and More Instantly...
ACHV - Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference

SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation...
ACHV - Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025

SEATTLE and VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation...

ACHV - Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation

2025-07-07 13:55:46 ET Thesis overview Achieve Life Sciences ( ACHV ) is a late-stage pre-commercial pharmaceutical company developing cytisinicline for smoking and e-cigarette cessation. ACHV announced a few days ago a NDA submission based on a data package which I believe ...

ACHV - Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities

SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation...
ACHV - Achieve Life Sciences partners with Omnicom for product launch

2025-06-27 10:37:35 ET More on Achieve Life Sciences, Omnicom Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk Omnicom Group: Poised For A Breakout With IPG Acquisition And AI-Led Transformation Omnicom: Deteriorating Forecasts Ac...

ACHV - Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering

2025-06-27 03:11:17 ET Achieve Life Sciences ( NASDAQ: ACHV ) has announced the pricing of an underwritten public offering of 15M shares of its common stock and accompanying common warrants to purchase up to 15M shares of common stock, for an expected gross proceeds to be approx...

ACHV - Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation...
ACHV - Achieve Life Sciences announces proposed public offering; shares down nearly 13%

2025-06-26 16:12:52 ET More on Achieve Life Sciences Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript Achieve Life Sciences targets NDA submission for cytisinicline in Ju...

ACHV - Achieve Life Sciences Announces Proposed Underwritten Public Offering

SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation...

ACHV - Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

Omnicom cross-agency collaboration to drive technology-led, innovative launch strategy Partnership brings together promising science, top-tier talent, and advanced technologies to enable a faster, smarter, and more effective path to address a critical public health need SEATTLE and ...
Previous 10 Next 10